# Pipeline Version 2.2

**Created:** May 24, 2025  
**Based on:** pipeline_v2.1 (May 23, 2025 run)  
**Status:** Development - Targeted Fixes

## Changes from v2.1

This version addresses the critical validation issues identified in the v2.1 analysis:

### ðŸŽ¯ **Target Fixes (In Progress)**

1. **MAGE Tissue Mapping Failure**
   - Issue: 0% tissue validation rate for "lymphoblast"
   - Fix: Update tissue_to_uberon.json with proper lymphoblast mapping

2. **ADNI Data Type Validation**
   - Issue: 0% valid data_type values
   - Fix: Review and correct ADNI data_type standardization logic

3. **ENCODE Gene ID Format Detection**
   - Issue: Validation showing "Unknown" instead of "Ensembl"
   - Fix: Update validation logic in validate_standardized_datasets.py

### ðŸ“‹ **Additional Improvements**

4. **ADNI "Worst Diagnosis Over Time"**
   - Implement derivation from longitudinal diagnosis data

5. **Enhanced GTEx Gene Mapping**
   - Target: Improve from 92.8% to >95% mapping rate

6. **Pipeline Documentation**
   - Updated METADATA_PROGRESS_VALIDATION_PLAN.md with v2.1 analysis
   - Added comprehensive issue tracking and success metrics

## Expected Outcomes

- **Gene Mapping:** Maintain >99% rate, improve GTEx performance
- **Validation:** Achieve 100% pass rate across all datasets
- **Metadata Quality:** Complete ontology mappings for all required fields
- **Production Readiness:** Address all critical validation issues

## Files Modified

- `tissue_to_uberon.json` (planned)
- `standardize_datasets.py` or `rnaseq_utils.py` (ADNI data_type fix)
- `validate_standardized_datasets.py` (gene ID format detection)
- Additional metadata processing scripts as needed

---

**Previous Version:** [pipeline_v2.1](../pipeline_v2.1/) - Production pipeline with exceptional gene mapping (100% ENCODE rate)  
**Next Version:** v2.3 (planned) - WGS integration and single-cell expansion